Regulatory Rapporteur November 2005

Volume 2 Issue 11
In This Issue
- Focus on promotional activities. What are the rules?
- Mutual Recognition and Decentralised Procedures - interview with Shirley Norton
- 10 years of EMEA CNS Medicines - Antipsychotic treatments
Please login to view member only articles. Non-members may download the public articles.
Title | Download | Category | Size | File |
---|---|---|---|---|
Regulatory Rapporteur November 2005 | Members | Full Issue | 2MB | |
Worldwide survey on national controls of pharmaceutical advertising and promotion | Public | 202KB | ||
10 Years of EMEA CNS Medicines | Members | 440KB | ||
Beware the ads of March? | Members | 103KB | ||
EU Regulatory Intelligence: Updates October 2005 | Members | 150KB | ||
Mutual Recognition and Decentralised Procedures | Members | 295KB | ||
New Medicines Legislation – Working with the MHRA | Members | 169KB | ||
Sales and marketing practices for prescription medicines: New rules in a new environment. | Members | 255KB | ||
The Exchange: Co-ordinated by Origin Pharmaceutical Services Limited | Members | 156KB | ||
The history of medical device regulations | Members | 177KB | ||
The Spanish Code of Practice for the Promotion of Medicines | Members | 613KB |